Literature DB >> 9559943

Functional thrombin receptor PAR1 in primary cultures of human glioblastoma cells.

R Kaufmann1, S Patt, H Schafberg, R Kalff, G Neupert, G Nowak.   

Abstract

In this study we investigated primary cultures obtained from two glioblastomas surgically removed from a 64-year-old man and a 50-year-old woman, respectively. The presence of the tethered ligand thrombin receptor PAR1 (protease-activated receptor 1) in these cells was demonstrated at the level of receptor binding by using immunofluorescence studies with the monoclonal anti-PAR1 antibody Mab 31-2. Stimulation of human glioblastoma cells both with alpha-thrombin and the thrombin receptor activating peptide TRAP-6 resulted in a series of [Ca+]i spikes as shown by confocal laser fluorescence microscopy with fluo-3 as calcium sensitive fluorescence indicator. This effect was completely blocked with the thrombin receptor antagonist peptide T1. Our results demonstrate functional thrombin receptors (PAR1) in primary cultures of human glioblastomas for the first time.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559943     DOI: 10.1097/00001756-199803090-00027

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  7 in total

1.  Expression of coagulation factors and their receptors in tumor tissue and coagulation factor upregulation in peripheral blood of patients with cerebral carcinoma metastases.

Authors:  Jan Walter; Linn L Handel; Michael Brodhun; Denise van Rossum; Uwe-Karsten Hanisch; Lutz Liebmann; Frank Heppner; Roland Goldbrunner; Arend Koch; Susanne A Kuhn
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-08       Impact factor: 4.553

2.  The effects of stimulating protease-activated receptor-1 and -2 in A172 human glioblastoma.

Authors:  T Okamoto; M Nishibori; K Sawada; H Iwagaki; N Nakaya; A Jikuhara; N Tanaka; K Saeki
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

3.  PAR 1-type thrombin receptors are involved in thrombin-induced calcium signaling in human meningioma cells.

Authors:  R Kaufmann; S Patt; R Kraft; M Zieger; P Henklein; G Neupert; G Nowak
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

Review 4.  Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer.

Authors:  Andrea Pia Elste; Iver Petersen
Journal:  J Mol Histol       Date:  2010-06-20       Impact factor: 2.611

5.  Thrombin Activity and Thrombin Receptor in Rat Glioblastoma Model: Possible Markers and Targets for Intervention?

Authors:  Ze'ev Itsekson-Hayosh; Efrat Shavit-Stein; David Last; David Goez; Dianne Daniels; Doron Bushi; Orna Gera; Zion Zibly; Yael Mardor; Joab Chapman; Sagi Harnof
Journal:  J Mol Neurosci       Date:  2015-02-19       Impact factor: 3.444

6.  PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo.

Authors:  R Auvergne; C Wu; A Connell; S Au; A Cornwell; M Osipovitch; A Benraiss; S Dangelmajer; H Guerrero-Cazares; A Quinones-Hinojosa; S A Goldman
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

7.  Expression of functional protease-activated receptor 1 in human prostate cancer cell lines.

Authors:  Jian Liu; Manuela Bastian; Peter Kohlschein; Peter Schuff-Werner; Michael Steiner
Journal:  Urol Res       Date:  2003-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.